AF
Andrew Fein HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
109
Avg Return
Past Year
Past Year
43%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $641 |
46%
upside
| 3 | +1.2% |
0
%
| 10 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $55 |
46%
upside
| 1 | +17% |
0
%
| 6 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $34 |
94%
upside
| 2 | +47% |
0
%
| 4 Mar ‘26 1 month ago |
|
|
|
Buy
Reiterated
| $30 |
296%
upside
| 2 | +11% |
0
%
| 2 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $600 |
5%
upside
| 1 | +13% |
0
%
| 26 Feb ‘26 1 month ago |
|
|
|
Buy
Maintained
| $255 |
97%
upside
| 1 | +29% |
0
%
| 24 Feb ‘26 1 month ago |
|
|
|
Buy
Reiterated
| $230 |
61%
upside
| 2 | +20% |
0
%
| 23 Feb ‘26 1 month ago |
|
|
|
Buy
Maintained
| $192 |
46%
upside
| 2 | +12% |
0
%
| 12 Feb ‘26 2 months ago |
|
|
|
Buy
Maintained
| $228 |
24%
upside
| 1 | +14% |
0
%
| 9 Feb ‘26 2 months ago |
|